Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emre Kocakavuk

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Seminars in Nuclear Medicine|January 29, 2021
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future PerspectivesRobert Seifert, Manuel Weber, Emre Kocakavuk, et al.
Neuro-Oncology|November 15, 2024
Gene expression signature-defined necroinflammation is not associated with sex-biased survival or bevacizumab benefit in glioblastomaJohannes Weller, Emre Kocakavuk, Barbara Pregler, et al.
Neuro-Oncology|June 17, 2023
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomasEmre Kocakavuk, Kevin C Johnson, Thais S Sabedot, et al.
Nature Genetics|May 28, 2021
Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancerEmre Kocakavuk, Kevin J Anderson, Frederick S Varn, et al.
Clinical Neurology and Neurosurgery|January 14, 2024
Extent of resection for low-grade gliomas - Prognostic or therapeutic?Connor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Brain Pathology (Zurich, Switzerland)|March 6, 2018
Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's diseaseKathy Keyvani, Yvonne Münster, Nirup K Kurapati, et al.
NPJ Parkinson'S Disease|August 15, 2024
Risk willingness in multiple system atrophy and Parkinson's disease understanding patient preferencesAlexander Maximilian Bernhardt, Marc Oeller, Isabel Friedrich, et al.
Cancer Cell|February 13, 2020
Comparative Molecular Life History of Spontaneous Canine and Human GliomasSamirkumar B Amin, Kevin J Anderson, C Elizabeth Boudreau, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Nature|June 3, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progressionKevin C Johnson, Avishay Spitzer, Frederick S Varn, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Seminars in Nuclear Medicine|January 29, 2021
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future PerspectivesRobert Seifert, Manuel Weber, Emre Kocakavuk, et al.
Neuro-Oncology|November 15, 2024
Gene expression signature-defined necroinflammation is not associated with sex-biased survival or bevacizumab benefit in glioblastomaJohannes Weller, Emre Kocakavuk, Barbara Pregler, et al.
Neuro-Oncology|June 17, 2023
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomasEmre Kocakavuk, Kevin C Johnson, Thais S Sabedot, et al.
Nature Genetics|May 28, 2021
Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancerEmre Kocakavuk, Kevin J Anderson, Frederick S Varn, et al.
Clinical Neurology and Neurosurgery|January 14, 2024
Extent of resection for low-grade gliomas - Prognostic or therapeutic?Connor J Kinslow, Andrew L A Garton, Ali I Rae, et al.
Brain Pathology (Zurich, Switzerland)|March 6, 2018
Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's diseaseKathy Keyvani, Yvonne Münster, Nirup K Kurapati, et al.
NPJ Parkinson'S Disease|August 15, 2024
Risk willingness in multiple system atrophy and Parkinson's disease understanding patient preferencesAlexander Maximilian Bernhardt, Marc Oeller, Isabel Friedrich, et al.
Cancer Cell|February 13, 2020
Comparative Molecular Life History of Spontaneous Canine and Human GliomasSamirkumar B Amin, Kevin J Anderson, C Elizabeth Boudreau, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Nature|June 3, 2026
Acquired genetic and cell-state changes in IDH-mutant glioma progressionKevin C Johnson, Avishay Spitzer, Frederick S Varn, et al.
Pageof 2